TheraSource

About:

TheraSource is a growing biotech company

Top Investors: National Institutes of Health

Description:

TheraSource is a growing biotech company founded in 2004 and located in the Greater New York area. Our mission is to develop novel anti-inflammatory therapeutics for the treatment of human diseases. Our founder and scientists have demonstrated the efficacy of several newly-discovered molecules in preclinical studies of various medical conditions including ischemic acute kidney injury (AKI), inflammatory bowel disease (IBD), acute ischemic stroke, acute radiation syndrome, shock and sepsis, leading to >250 peer-reviewed publications.

Total Funding Amount:

$3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Manhasset, New York, United States

Founded Date:

2004-01-01

Contact Email:

Info(AT)therasourcellc.com

Founders:

Ping Wang

Number of Employees:

11-50

Last Funding Date:

2016-05-14

IPO Status:

Private

Industries: